| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,330,000 | 3,314,000 | 3,188,000 | 2,902,000 | 2,512,000 |
| Cost of Revenue
|
-842,000 | -885,000 | -931,000 | -872,000 | -738,000 |
|
Gross Profit
|
2,488,000 | 2,429,000 | 2,257,000 | 2,030,000 | 1,774,000 |
|
Selling, General and Administrative Expenses
|
-885,000 | -869,000 | -872,000 | -808,000 | -717,000 |
|
Research and Development Expenses
|
-243,000 | -252,000 | -262,000 | -228,000 | -218,000 |
| Depreciation, Amortization and Depletion
|
-439,000 | -406,000 | -361,000 | -384,000 | -420,000 |
|
Operating Income/Expenses
|
-1,567,000 | -1,527,000 | -1,495,000 | -1,420,000 | -1,355,000 |
|
Total Operating Profit/Loss
|
921,000 | 902,000 | 762,000 | 610,000 | 419,000 |
| Total Net Finance Income/Expense
|
-330,000 | -319,000 | -295,000 | -324,000 | -474,000 |
| Irregular Income/Expenses
|
-244,000 | -219,000 | -94,000 | -92,000 | -146,000 |
|
Other Income/Expense, Non-Operating
|
29,000 | 1,000 | 48,000 | 11,000 | 38,000 |
|
Non-Operating Income/Expenses, Total
|
-545,000 | -537,000 | -341,000 | -405,000 | -582,000 |
|
Pretax Income
|
376,000 | 365,000 | 421,000 | 205,000 | -163,000 |
|
Provision for Income Tax
|
-86,000 | -89,000 | -85,000 | -25,000 | -13,000 |
|
Net Income from Continuing Operations
|
290,000 | 276,000 | 336,000 | 180,000 | -176,000 |
|
Discontinued Operations
|
0 | -- | 0 | 0 | 3,873,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
290,000 | 276,000 | 336,000 | 180,000 | 3,697,000 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 0 | -17,000 | -22,000 |
|
Net Income after Non-Controlling/Minority Interests
|
290,000 | 276,000 | 336,000 | 163,000 | 3,675,000 |
|
Net Income Available to Common Stockholders
|
290,000 | 276,000 | 336,000 | 163,000 | 3,675,000 |
|
Diluted Net Income Available to Common Stockholders
|
290,000 | 276,000 | 336,000 | 163,000 | 3,675,000 |
| Basic EPS
|
3.78 | 3.32 | 3.77 | 1.79 | 38.78 |
| Diluted EPS
|
3.71 | 3.26 | 3.68 | 1.75 | 38.78 |
|
Basic Weighted Average Shares Outstanding
|
77,600 | 83,000 | 89,000 | 91,000 | 95,000 |
|
Diluted Weighted Average Shares Outstanding
|
79,375 | 85,000 | 91,000 | 93,000 | 95,000 |
|
Reported Normalized Diluted EPS
|
7.22 | 6.69 | 5.27 | 4.18 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
704,000 | 679,000 | 714,000 | 514,000 | 164,000 |
|
EBITDA
|
1,143,000 | 1,085,000 | 1,075,000 | 898,000 | 584,000 |
|
Normalized EBITDA
|
1,387,000 | 1,443,000 | 1,244,000 | 1,118,000 | 913,000 |
12/31/2022 - 8/23/1984
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade